Published in Gene Therapy Weekly, December 11th, 2008
"Despite extensive T cell depletion of bone marrow, ail intensive conditioning regimen, and immunosuppressive graft-versus-host disease (GvHD) prophylaxis, infusion at the time of TCD-BMT of this low number of GMCs Sufficed to induce a rapid GMC-specific immune response, as detected by interferon-y...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.